Mon, May 22, 2023

Vernon Bernardino Reiterated (CADL) at Strong Buy and Held Target at $11 on, May 22nd, 2023

Vernon Bernardino of HC Wainwright & Co., Reiterated "Candel Therapeutics, Inc." (CADL) at Strong Buy and Held Target at $11 on, May 22nd, 2023.

Vernon has made no other calls on CADL in the last 4 months.



There are 2 other peers that have a rating on CADL. Out of the 2 peers that are also analyzing CADL, 0 agree with Vernon's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Vernon


  • Evan David Seigerman of "BMO Capital" Maintained at Buy with Decreased Target to $3 on, Monday, May 15th, 2023
  • Judah Frommer of "Credit Suisse" Maintained at Buy with Decreased Target to $7 on, Friday, March 31st, 2023